Treatment of Metastatic Renal Cancer With High-dose Interleukin-2 After Targeted Therapy Can Be Given Safely and Can Produce High Rates of Response Including Complete Remissions
European Journal of Cancer（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要